A multicenter study of the clonal structure and resistance mechanism of KPC-producing Escherichia coli isolates in Israel

Clinical Microbiology and Infection

Volumn 21, Issue 3, 2015, Pages 230-235

  Adler, A ^a,b   Miller Roll, T ^a,b   Assous, M V ^c   Geffen, Y ^d   Paikin, S ^e   Schwartz, D ^b   Weiner Well, Y ^c   Hussein, K ^d   Cohen, R ^f   Carmeli, Y ^a,b  

^a MINISTRY OF HEALTH   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

^d RAMBAM MEDICAL CENTER   (Israel)

^e LANIADO HOSPITAL   (Israel)

^f TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Clonal structure; E.coli; KPC carbapenemase; Plasmids; Transmission

Indexed keywords

AMIKACIN; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL STRUCTURES; BACTERIUM ISOLATE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CLONE; ESCHERICHIA COLI; HORIZONTAL GENE TRANSFER; ISRAEL; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; CLASSIFICATION; CLINICAL TRIAL; DNA SEQUENCE; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTICENTER STUDY; PLASMID;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; ISRAEL; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PLASMIDS; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA;

EID: 84933527786     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2014.10.008     Document Type: Article

References (32)

1. Schwaber M.J., Lev B., Israeli A., Solter E., Smollan G., Rubinovitch B., et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011, 52:848-855.
2. Navon-Venezia S., Leavitt A., Schwaber M.J., Rasheed J.K., Srinivasan A., Patel J.B., et al. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother 2009, 53:818-820.
3. Adler A., Paikin S., Sterlin Y., Glick J., Edgar R., Aronov R., et al. Aswordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone. JClin Microbiol 2012, 50:3180-3185.
4. Goren M.G., Navon-Venezia S., Chmelnitsky I., Carmeli Y. Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008. Antimicrob Agents Chemother 2010, 54:2687-2691.
5. Marchaim D., Navon-Venezia S., Schwaber M.J., Carmeli Y. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother 2008, 52:1413-1418.
6. Feldman N., Adler A., Molshatzki N., Navon-Venezia S., Khabra E., Cohen D., et al. Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage. Clin Microbiol Infect 2013, 19:E190-E196.
7. Rogers B.A., Sidjabat H.E., Paterson D.L. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. JAntimicrob Chemother 2011, 66:1-14.
8. Kim Y.A., Qureshi Z.A., Adams-Haduch J.M., Park Y.S., Shutt K.A., Doi Y. Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131. Clin Infect Dis 2012, 55:224-231.
9. Naas T., Cuzon G., Gaillot O., Courcol R., Nordmann P. When carbapenem-hydrolyzing {beta}-lactamase KPC meets Escherichia coli ST131 in France. Antimicrob Agents Chemother 2011, 55:4933-4934. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/21768511.
10. Adler A., Navon-Venezia S., Moran-Gilad J., Marcos E., Schwartz D., Carmeli Y., et al. Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant enterobacteriaceae from surveillance rectal swabs. JClin Microbiol 2011, 49:2239-2242.
11. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard 2012, CLSI, Wayne, PA. 9th edition.
12. Clinical and Laboratory Standards Institute (CLSI) M100-S23 Performance standards for antimicrobial susceptibility testing; Twenty-third informational supplement 2013, CLSI, Wayne, PA.
13. Schechner V., Straus-Robinson K., Schwartz D., Pfeffer I., Tarabeia J., Moskovich R., et al. Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family. JClin Microbiol 2009, 47:3261-3265.
14. Poirel L., He C., Tolu V., Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004, 48:15-22.
15. Ellington M.J., Kistler J., Livermore D.M., Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. JAntimicrob Chemother 2007, 59:321-322.
16. Woodford N., Fagan E.J., Ellington M.J. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. JAntimicrob Chemother 2006, 57:154-155.
17. Schlesinger J., Navon-Venezia S., Chmelnitsky I., Hammer-Münz O., Leavitt A., Gold H.S., et al. Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel. Antimicrob Agents Chemother 2005, 49:1150-1156.
18. Chmelnitsky I., Carmeli Y., Leavitt A., Schwaber M.J., Navon-Venezia S. CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum beta-lactamases in multiple Escherichia coli clones isolated in Tel Aviv, Israel. Antimicrob Agents Chemother 2005, 49:4745-4750.
19. Wirth T., Falush D., Lan R., Colles F., Mensa P., Wieler L.H., et al. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006, 60:1136-1151.
20. Feil E.J., Li B.C., Aanensen D.M., Hanage W.P., Spratt B.G. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. JBacteriol 2004, 186:1518-1530.
21. Leavitt A., Carmeli Y., Chmelnitsky I., Goren M.G., Ofek I., Navon-Venezia S. Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel. Antimicrob Agents Chemother 2010, 54:3002-3006.
22. Carattoli A., Bertini A., Villa L., Falbo V., Hopkins K.L., Threlfall E.J. Identification of plasmids by PCR-based replicon typing. JMicrobiol Methods 2005, 63:219-228.
23. García-Fernández A., Villa L., Moodley A., Hasman H., Miriagou V., Guardabassi L., et al. Multilocus sequence typing of IncN plasmids. JAntimicrob Chemother 2011, 66:1987-1991.
24. Chmelnitsky I., Shklyar M., Leavitt A., Sadovsky E., Navon-Venezia S., Ben Dalak M., et al. Mix and match of KPC-2 encoding plasmids in Enterobacteriaceae-comparative genomics. Diagn Microbiol Infect Dis 2014, 79:255-260.
25. Baraniak A., Grabowska A., Izdebski R., Fiett J., Herda M., Bojarska K., et al. Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009. Antimicrob Agents Chemother 2011, 55:5493-5499.
26. Morris D., Boyle F., Ludden C., Condon I., Hale J., O'Connell N., et al. Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob Agents Chemother 2011, 55:4935-4936.
27. Izdebski R., Baraniak A., Fiett J., Adler A., Kazma M., Salomon J., et al. Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries. Antimicrob Agents Chemother 2013, 57:309-316.
28. Hilty M., Betsch B.Y., Bögli-Stuber K., Heiniger N., Stadler M., Küffer M., et al. Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis 2012, 55:967-975.
29. Leavitt A., Navon-Venezia S., Chmelnitsky I., Schwaber M.J., Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 2007, 51:3026-3029.
30. Adler A., Gniadkowski M., Baraniak A., Izdebski R., Fiett J., Hryniewicz W., et al. Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre. Clin Microbiol Infect 2012, 18:E497-E505.
31. Goren M.G., Carmeli Y., Schwaber M.J., Chmelnitsky I., Schechner V., Navon-Venezia S. Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient. Emerg Infect Dis 2010, 16:1014-1017.
32. Mathers A.J., Cox H.L., Kitchel B., Bonatti H., Brassinga A.K., Carroll J., et al. Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceae reveals Intergenus KPC carbapenemase transmission through a promiscuous plasmid. MBio 2011, 2:e00204-e00211.